Notice of Proposed Sale · 144
Xeris Biopharma Holdings, Inc.
XERSNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- XERIS BIOPHARMA HOLDINGS, INC.
- Issuer CIK
- 0001867096
- SEC file number
- 001-40880
- Phone
- 8444455704
- Person for whose account securities are to be sold
- STEVEN PIEPER
- Relationships to issuer
- Officer
- Street
- 1375 West Fulton Street, Suite 1300
- City
- Chicago
- State / country code
- IL
- Postal code
- 60607
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 27,600 | 231,012.00 | 172,642,055 | 07/07/2026 | NASDAQ | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 05/17/2017 | Open Market Purchase | Issuer | 4,600 | N | 05/17/2017 | Cash |
| Common | 12/28/2017 | Restricted Stock Units | Issuer | 23,000 | N | 12/28/2017 | N/A |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| 10b5-1 Sales for STEVEN PIEPER | Common | 07/06/2026 | 17,400 | 147,900.00 |
Seller — prior-sale row 1, entry 1
- Name
- 10b5-1 Sales for STEVEN PIEPER
- Street
- 1375 West Fulton Street, Suite 1300
- City
- Chicago
- State / country code
- IL
- Postal code
- 60607
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
The securities to be sold were acquired upon the vesting of restricted stock units during the period of 12/28/2017 through 01/03/2025. The securities to be sold were acquired upon open market purchases during the period of 05/17/2017 through 02/13/2019.
Notice signature
- Notice date
- 07/07/2026
- Signed
- /s/ Steven Pieper
- Plan adoption dates
- 08/18/2025